Literature DB >> 26541678

How an artery heals.

Kevin Jon Williams1, Ira Tabas2, Edward A Fisher2.   

Abstract

Entities:  

Keywords:  Editorial; atherosclerosis; endothelial function; lipids and lipoproteins; low-density lipoprotein; macrophage

Mesh：

Substances：

Year:  2015        PMID： 26541678      PMCID： PMC4663458          DOI： 10.1161/CIRCRESAHA.115.307609

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  26 in total

1.  The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin Cytoskeleton, Rho family GTPases, and myosin ATPase activity.

Authors:  S W Sakr; R J Eddy; H Barth; F Wang; S Greenberg; F R Maxfield; I Tabas
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

Review 2.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

3.  Lipoprotein retention--and clues for atheroma regression.

Authors:  Kevin Jon Williams; Ira Tabas
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-08       Impact factor: 8.311

4.  Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Authors:  Christopher P Cannon; Michael A Blazing; Robert P Giugliano; Amy McCagg; Jennifer A White; Pierre Theroux; Harald Darius; Basil S Lewis; Ton Oude Ophuis; J Wouter Jukema; Gaetano M De Ferrari; Witold Ruzyllo; Paul De Lucca; KyungAh Im; Erin A Bohula; Craig Reist; Stephen D Wiviott; Andrew M Tershakovec; Thomas A Musliner; Eugene Braunwald; Robert M Califf
Journal:  N Engl J Med       Date:  2015-06-03       Impact factor: 91.245

5.  Remnant cholesterol as a causal risk factor for ischemic heart disease.

Authors:  Anette Varbo; Marianne Benn; Anne Tybjærg-Hansen; Anders B Jørgensen; Ruth Frikke-Schmidt; Børge G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2012-12-19       Impact factor: 24.094

Review 6.  Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors:  Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-16       Impact factor: 8.311

7.  Altered metabolism of LDL in the arterial wall precedes atherosclerosis regression.

Authors:  Emil D Bartels; Christina Christoffersen; Marie W Lindholm; Lars B Nielsen
Journal:  Circ Res       Date:  2015-09-10       Impact factor: 17.367

8.  Disturbed Laminar Blood Flow Vastly Augments Lipoprotein Retention in the Artery Wall: A Key Mechanism Distinguishing Susceptible From Resistant Sites.

Authors:  Lasse Bach Steffensen; Martin Bødtker Mortensen; Mads Kjolby; Mette Kallestrup Hagensen; Claus Oxvig; Jacob Fog Bentzon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-07-16       Impact factor: 8.311

9.  Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Authors:  Marc S Sabatine; Robert P Giugliano; Stephen D Wiviott; Frederick J Raal; Dirk J Blom; Jennifer Robinson; Christie M Ballantyne; Ransi Somaratne; Jason Legg; Scott M Wasserman; Robert Scott; Michael J Koren; Evan A Stein
Journal:  N Engl J Med       Date:  2015-03-15       Impact factor: 91.245

10.  Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.

Authors:  Jennifer G Robinson; Michel Farnier; Michel Krempf; Jean Bergeron; Gérald Luc; Maurizio Averna; Erik S Stroes; Gisle Langslet; Frederick J Raal; Mahfouz El Shahawy; Michael J Koren; Norman E Lepor; Christelle Lorenzato; Robert Pordy; Umesh Chaudhari; John J P Kastelein
Journal:  N Engl J Med       Date:  2015-03-15       Impact factor: 91.245
View more
  4 in total

1.  Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.

Authors:  Paul A Mueller; Lin Zhu; Hagai Tavori; Katherine Huynh; Ilaria Giunzioni; John M Stafford; MacRae F Linton; Sergio Fazio
Journal:  Circulation       Date:  2018-10-23       Impact factor: 29.690

2.  Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.

Authors:  Keyang Chen; Qingsi Wu; Kongwang Hu; Chengwei Yang; Xiangdong Wu; Peter Cheung; Kevin Jon Williams
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

3.  Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.

Authors:  Jan Borén; M John Chapman; Ronald M Krauss; Chris J Packard; Jacob F Bentzon; Christoph J Binder; Mat J Daemen; Linda L Demer; Robert A Hegele; Stephen J Nicholls; Børge G Nordestgaard; Gerald F Watts; Eric Bruckert; Sergio Fazio; Brian A Ference; Ian Graham; Jay D Horton; Ulf Landmesser; Ulrich Laufs; Luis Masana; Gerard Pasterkamp; Frederick J Raal; Kausik K Ray; Heribert Schunkert; Marja-Riitta Taskinen; Bart van de Sluis; Olov Wiklund; Lale Tokgozoglu; Alberico L Catapano; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2020-06-21       Impact factor: 29.983

Review 4.  Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.

Authors:  Jennifer G Robinson; Kevin Jon Williams; Samuel Gidding; Jan Borén; Ira Tabas; Edward A Fisher; Chris Packard; Michael Pencina; Zahi A Fayad; Venkatesh Mani; Kerry Anne Rye; Børge G Nordestgaard; Anne Tybjærg-Hansen; Pamela S Douglas; Stephen J Nicholls; Neha Pagidipati; Allan Sniderman
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.